Cargando…
Saccharomyces boulardii Combined With Quadruple Therapy for Helicobacter pylori Eradication Decreased the Duration and Severity of Diarrhea: A Multi-Center Prospective Randomized Controlled Trial
Background: Whether probiotics helped the Helicobacter pylori (H. pylori) eradication was still highly controversial. The non-bacterial Saccharomyces boulardii (S. boulardii) has demonstrated its efficacy in the treatment of antibiotic-associated and infectious diarrhea. We aimed to evaluate the eff...
Autores principales: | Zhao, Yuchong, Yang, Yilei, Aruna, Xiao, Jun, Song, Jun, Huang, Tizheng, Li, Shuyu, Kou, Jiguang, Huang, Lu, Ji, Dexiong, Xiong, Si, Peng, Wang, Xu, Sanping, Cheng, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637152/ https://www.ncbi.nlm.nih.gov/pubmed/34869495 http://dx.doi.org/10.3389/fmed.2021.776955 |
Ejemplares similares
-
Saccharomyces Boulardii in Helicobacter Pylori Eradication in Children: A Randomized Trial From Iran
por: Namkin, Kokab, et al.
Publicado: (2016) -
The efficacy and safety of Saccharomyces boulardii in addition to antofloxacin-based bismuth quadruple therapy for Helicobacter pylori eradication: a single-center, prospective randomized-control study
por: He, Xiao-Jian, et al.
Publicado: (2023) -
The Efficacy of Saccharomyces boulardii CNCM I-745 in Addition to Standard Helicobacter pylori Eradication Treatment in Children
por: Bin, Zhang, et al.
Publicado: (2015) -
Saccharomyces boulardii Allows Partial Patients to Avoid Reusing Bismuth Quadruple for Helicobacter pylori Rescue Therapy: A Single-Center Randomized Controlled Study
por: Qu, Peng, et al.
Publicado: (2022) -
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori
por: Gisbert, Javier P, et al.
Publicado: (2012)